» Articles » PMID: 24343104

Retrograde Ductal Administration of the Adenovirus-mediated NDRG2 Gene Leads to Improved Sialaden Hypofunction in Estrogen-deficient Rats

Overview
Journal Mol Ther
Publisher Cell Press
Date 2013 Dec 18
PMID 24343104
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

One of the most common oral manifestations of menopause is xerostomia. Oral dryness can profoundly affect quality of life and interfere with basic daily functions, such as chewing, deglutition, and speaking. Although the feeling of oral dryness can be ameliorated after estrogen supplementation, the side effects of estrogen greatly restrict its application. We previously found that N-myc downstream-regulated gene 2 (NDRG2) is involved in estrogen-mediated ion and fluid transport in a cell-based model. In the present study, we used an ovariectomized rat model to mimic xerostomia in menopausal women and constructed two adenovirus vectors bearing NDRG2 to validate their therapeutic potential. Ovariectomized rats exhibited severe sialaden hypofunction, including decreased saliva secretion and ion reabsorption as well as increased water intake. Immunohistochemistry revealed that the expression of NDRG2 and Na(+) reabsorption-related Na(+)/K(+)-ATPase and epithelial sodium channels (EnaC) decreased in ovariectomized rat salivary glands. We further showed that the localized delivery of NDRG2 improved the dysfunction of Na(+) and Cl(-) reabsorption. In addition, the saliva flow rate and water drinking recovered to normal. This study elucidates the mechanism of estrogen deficiency-mediated xerostomia or sialaden hypofunction and provides a promising strategy for therapeutic intervention.

Citing Articles

The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis.

Lee K, Lim S, Kim K Int J Mol Sci. 2022; 23(16).

PMID: 36012631 PMC: 9408851. DOI: 10.3390/ijms23169365.


N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor.

Kim G, Lim S, Kim K Cells. 2021; 10(10).

PMID: 34685629 PMC: 8534062. DOI: 10.3390/cells10102649.


Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application.

Kratzer K, Getz L, Peterlini T, Masson J, Dellaire G Hum Genet. 2021; 141(6):1175-1193.

PMID: 33834266 DOI: 10.1007/s00439-021-02272-5.


NDRG2 is expressed on enteric glia and altered in conditions of inflammation and oxygen glucose deprivation/reoxygenation.

Zhang Y, Gao H, Li N, Chang H, Cheng B, Li Y J Mol Histol. 2020; 52(1):101-111.

PMID: 33205345 DOI: 10.1007/s10735-020-09927-z.


Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort study.

Gu A, Xu J, Ye J, Zhang C Medicine (Baltimore). 2020; 99(41):e22678.

PMID: 33031336 PMC: 7544425. DOI: 10.1097/MD.0000000000022678.


References
1.
Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S . Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol. 1992; 73(5):570-4. DOI: 10.1016/0030-4220(92)90100-5. View

2.
Catalan M, Nakamoto T, Gonzalez-Begne M, Camden J, Wall S, Clarke L . Cftr and ENaC ion channels mediate NaCl absorption in the mouse submandibular gland. J Physiol. 2009; 588(Pt 4):713-24. PMC: 2828142. DOI: 10.1113/jphysiol.2009.183541. View

3.
Wielputz M, Lee I, Dinudom A, Boulkroun S, Farman N, Cook D . (NDRG2) stimulates amiloride-sensitive Na+ currents in Xenopus laevis oocytes and fisher rat thyroid cells. J Biol Chem. 2007; 282(38):28264-73. DOI: 10.1074/jbc.M702168200. View

4.
Wang H, ODoherty G . Modulators of Na/K-ATPase: a patent review. Expert Opin Ther Pat. 2012; 22(6):587-605. DOI: 10.1517/13543776.2012.690033. View

5.
Wolff A, Fox P, Porter S, Konttinen Y . Established and novel approaches for the management of hyposalivation and xerostomia. Curr Pharm Des. 2012; 18(34):5515-21. DOI: 10.2174/138161212803307509. View